期刊文献+

早、中、晚孕期胎盘因子体外抗HIV-1的研究 被引量:4

Study on the 1st,2nd,and 3rd trimester placental factors against HIV-1 in vitro
下载PDF
导出
摘要 目的探讨早、中、晚孕期胎盘因子(PF)体外抗人免疫缺陷病毒-1(HIV-1)及在HIV-1垂直传播中的作用。方法荧光染料Calcien-AM标记的H9/HIV-1ⅢB分别与早、中、晚孕期不同稀释浓度的PF作用后,与MT2细胞混合培养,荧光显微镜下观察合胞体的形成;用HIV-1ⅢB感染MT2细胞,并分别与早、中、晚孕期不同稀释浓度的PF作用后,用MTT法检测HIV-1感染细胞的存活率,用ELISA方法检测细胞培养上清中p24抗原水平。结果各孕期PF并不能抑制MT2和H9/HIV-1ⅢB细胞的融合,但可以增加HIV-1感染细胞的存活率及减少HIV-1p24抗原的表达,且效应以早孕期PF最大,中孕期PF其次,晚孕期PF最小,并与剂量呈正相关。结论PF在体外具有抗HIV-1的作用,并呈现孕期和剂量相关性,可能在阻断HIV-1垂直传播中具有一定作用。 Objective To investigate the effects of the 1st, 2nd, and 3rd trimester placental factors (PFs) on human immunodeficiency virus type 1 ( HIV- 1) infection in vitro, and to evaluate their possible roles in HIV- 1 intrauterine infection. Methods Calcein-AM-stained H9/HIV-1ⅢB cells were treated with different concentrations of the 1st, 2nd, and 3rd trimester PFs, respectively, and then mixed with MT2 cells. HIV-1-mediated syncytium formation was observed under fluorescent microscope. MT2 cells were treated with cell-free HIV-1 Ⅲ B, then washed and cultured with different concentrations of the 1st, 2nd, and 3rd trimester PFs respectively. The protecting effect of PFs on HIV- 1-infected cells was determined with MTT; viral replication was evaluated by measuring the levels of p24 antigen in culture supernatants with ELISA. Results PFs did not suppress HIV-1-mediated syncyfium formation, but significantly increased HIV-1-infected cells' viability and decreased p24 levels in trimester- and concentration-dependent manner. Condusion PFs can reduce HIV-1 infection in vitro, and may have an important role in reducing HIV-1 vertical transmission via placenta.
出处 《免疫学杂志》 CAS CSCD 北大核心 2008年第2期230-233,共4页 Immunological Journal
关键词 胎盘因子 HIV-1 垂直传播 Calcien-AM Placental factor HIV-1 Vertical transmission Calcien-AM
  • 相关文献

参考文献14

  • 1Clark PA. Mother-to-child transmission of HIV in Botswana: an ethical perspective on mandatory testing[ J ]. Developing World Bioeth, 2006, 6(1): 1 - 12.
  • 2Coutsoudis A, Pillay K, Kuhn L, et al. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa[J]. AIDS, 2001, 15(3): 379-387.
  • 3Soilleux EJ, Coleman N. Transplacental transmission of HIV: a potential role for HIV binding lectins [J]. Int J Biochem Cell Biol, 2003, 35(3): 283- 287.
  • 4Schwartz DH, Sharma UK, Perlman EJ, et al. Adherence of human immunodeficiency virus-infected lymphocytes to fetal placental cells[J]. Proc Natl Acad Sci USA, 1995, 92(4): 978 - 982.
  • 5Kondapi AK, Hafiz MA, Sivaram T. Anti-HIV activity of a glycoprotein from first trimester placental tissue[ J]. Anfiviral Res, 21302, 54(1): 47-57.
  • 6Sharma UK, Trujillo J, Song HF, et al. A novel factor produced by placental cells with activity against HIV-1[J]. J Immunol, 1998, 161(11): 6406-6412.
  • 7Abramson LP, Stellmach V, Doll JA, et al. Wilm's tumor growth is suppressed by antiangiogenic pigment epithelium- derived factor in a xenograft model[ J]. J Pediatr Surg, 2003, 38(3) : 336 - 342.
  • 8Bourinbaiar AS, Powell JE, Stevens VC. The role of carboxyterminal portion of beta subunit of human chofionic gonadotropin in human immunodeficiency virus infection[ J]. Life Sciences, 1997, 61(11) : 149- 157.
  • 9Bobroski L, Sison A, Pestanar JP, et al. Mechanisms of transplacental wansmission of HIV-1:Ⅰ. Infection of fetal placental layers in the intervillous spaces [J ]. Appl Immunohistochem Mol Morphol, 1999, 7(4): 271 - 279.
  • 10Sheikh AU, Polliotti BM, Miller RK. Human immunodeficiency virus infection: in situ polymerase chain reaction localization in human placentas after in utero and in vitro infection [ J ]. Am J Obstet Gynecol, 2000, 182(1 Pt 1): 207-213.

同被引文献24

  • 1WS293-2008艾滋病和艾滋病毒感染诊断标准.
  • 2Wang X, Tan N, Douglas SD, et al. Morphine inhibits CD8 + Tcell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells. J Leukoc Biol, 2005, 78:772-776.
  • 3McCarthy L, Wetzel M, Sliker JK, et al. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend, 2001, 62:111-123.
  • 4Baum MK, Rafie C, Lai S, et al. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquit Immune Defic Syndr, 2009, 50:93-99.
  • 5Riazi M, Marcario JK, Samson FK, et al. Rhesus Macaque Model of Chronic Opiate Dependence and Neuro-AIDS: Longitudinal Assessment of Auditory Brainstem Responses and Visual Evoked Potentials. J Neuroimmune Pharmacol, 2009, 4:260-275.
  • 6Hassan NF, Campbell DE, Douglas SD. Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods, 1986, 95:273-276.
  • 7Wang X, Douglas SD, Peng JS, et al. An in Vitro Model ofMorphine Withdrawal Manifests the Enhancing Effect on HumanImmunodeficiency Virus Infection of Human T Lymphocytesthrough the Induction of Substance P. Am J Pathol, 2006, 169 : 1663-1670.
  • 8Hull M J, Juhascik M, Mazur F, et al. Fatalities associated with fentanyl and co-administered cocaine or opiates. J Forensic Sci, 2007, 52 : 1383-1388.
  • 9Haniseh W, Meyer LV. Determination of the heroin metabolite 6- monoacetyl-morphine in urine by high-performance liquidchromatography with electrochemical detection. J Anal Toxicol, 1993,17:48-50.
  • 10Bokhari SM, Hegde R, Callen S, et al. Morphine PotentiatesNeuropathogenesis of SIV Infection in Rhesus Macaques. JNeuroimmune Pharmacol, [2011-03-24]. http://www.springerlink, corn/content/h2 k2873240r38004.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部